Walleye Trading’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,700
Closed -$266K 5505
2022
Q3
$266K Hold
5,700
﹤0.01% 3459
2022
Q2
$250K Sell
5,700
-100
-2% -$5.5K ﹤0.01% 3529
2022
Q1
$420K Buy
5,800
+900
+18% +$64.9K ﹤0.01% 3090
2021
Q4
$397K Sell
4,900
-2,900
-37% -$291K ﹤0.01% 3181
2021
Q3
$908K Buy
7,800
+700
+10% +$91.6K ﹤0.01% 2311
2021
Q2
$1.18M Sell
7,100
-15,100
-68% -$2.36M ﹤0.01% 1973
2021
Q1
$3.1M Buy
+22,200
New +$3.62M 0.01% 986
2020
Q4
Sell
-4,500
Closed -$627K 5005
2020
Q3
$627K Sell
4,500
-10,200
-69% -$1.36M ﹤0.01% 2041
2020
Q2
$1.76M Buy
14,700
+12,500
+568% +$1.48M 0.01% 1210
2020
Q1
$220K Buy
+2,200
New +$265K ﹤0.01% 2528
2019
Q4
Sell
-1,500
Closed -$129K 4704
2019
Q3
$129K Sell
1,500
-2,800
-65% -$212K ﹤0.01% 3209
2019
Q2
$279K Buy
4,300
+3,300
+330% +$205K ﹤0.01% 2672
2019
Q1
$63K Buy
+1,000
New +$47K ﹤0.01% 3646
2018
Q4
Sell
-5,500
Closed -$314K 5429
2018
Q3
$314K Sell
5,500
-8,800
-62% -$550K ﹤0.01% 3362
2018
Q2
$1.14M Buy
14,300
+13,100
+1,092% +$1.09M 0.01% 1952
2018
Q1
$104K Buy
+1,200
New +$96.9K ﹤0.01% 3888
2017
Q4
Sell
-1,600
Closed -$146 4702
2017
Q3
$146 Buy
+1,600
New +$137K ﹤0.01% 3434

Other funds holding NVRO

Walleye Trading's NVRO Position: Q2 2025 in Review

Walleye Trading sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 14,599 shares — an estimated $85.3K sold.

Walleye Trading first reported a position in NVRO in Q3 2017 and held it in 13 quarters. The position peaked at $1.29M in Q2 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Walleye Trading reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Walleye Trading sold 14,599 NEVRO CORP. shares in Q2 2025, an estimated $85.3K.
  • Walleye Trading first reported a position in NEVRO CORP. in Q3 2017 and held it in 13 quarters.
  • Walleye Trading's NEVRO CORP. position peaked at $1.29M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Walleye Trading's 13F filing for Q2 2025, filed 13 Aug 2025.